Autor: Apostolia-Maria Tsimberidou

Apostolia-Maria Tsimberidou, MD Ph D Department of Investigational Cancer Therapeutics The University of Texas MD Anderson Cancer Center Houston, TX, USA Razelle Kurzrock Center for Personalized Cancer Therapy, UC San Diego – Moores Cancer Center La Jolla, CA, USA Kenneth C. Anderson MD Le Bow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, USA